This is a St. Louis news story, published by BGR, that relates primarily to Washington University news.
For more St. Louis news, you can click here:
more St. Louis newsFor more disease research news, you can click here:
more disease research newsFor more news from BGR, you can click here:
more news from BGROtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
popular insomnia drug. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest insomnia news, quality sleep news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
crucial sleepBGR
•Health
Health
77% Informative
A new study suggests that a popular insomnia drug might act as an unexpected Alzheimer’s preventative.
Researchers at Washington University in St. Louis found that the sleeping pill suvorexant (commonly prescribed for insomnia) may help reduce levels of those same proteins, even after just two nights of use.
VR Score
76
Informative language
73
Neutral language
50
Article tone
informal
Language
English
Language complexity
44
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
3
Source diversity
2
Affiliate links
no affiliate links
Small business owner?
